Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Observer-blind Trial to Assess the Immunogenicity and Safety of Third Dose Vaccination With AstraZeneca COVID-19 Vaccine or Pfizer/BioNTech COVID-19 Vaccine Among Thai Adults Receiving Two Doses of Sinovac

NCT05049226 is registered in ClinicalTrials.gov with Mahidol University as lead sponsor.

NCT NCT05049226
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05049226 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Observer-blind Trial to Assess the Immunogenicity and Safety of Third Dose Vaccination With AstraZeneca COVID-19 Vaccine or Pfizer/BioNTech COVID-19 Vaccine Among Thai Adults Receiving Two Doses of Sinovac
Lead sponsor
Mahidol University
Phase
Phase 2
Overall status
Completed
Start date
September 24, 2021
Completion date
February 22, 2022
Enrollment
1,250 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 infection, covid-19 vaccine